Re: “Rates and risk factors for persistent opioid use after cardiothoracic surgery: A cohort study”

We read with interest the study by Kurteva et al that characterized multiple factors associated with increased risk of persistent opioid use after cardiothoracic surgery. Given the importance of opioids and other analgesics around cardiothoracic surgery, when adverse reactions (AR) are present, patient outcomes may be affected. To complement Kurteva et al’s study, we conducted a local evaluation of cardiac surgery patients with AR labels for common analgesics and antibiotics and associated clinical implications...